Name Carboxymethylcellulose Sodium + Hypromellose
Classes Dermatological/Topical Agent
Ophthalmic Preparation
Lubricant and Irrigants
Diseases Ocular Irritation
Ophthalmic Disease

Carboxymethylcellulose Sodium + Hypromellose

Carboxymethylcellulose Sodium + Hypromellose ophthalmic drop is a combination of two lubricating agents used to relieve dry eyes. Carboxymethylcellulose Sodium is a synthetic polymer that acts as a lubricant and protects the eye from further irritation. Hypromellose is a semisynthetic polymer that also acts as a lubricant and provides a protective film over the ocular surface.

 

Carboxymethylcellulose Sodium + Hypromellose ophthalmic drop is indicated for the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun. It is also used to relieve dryness and irritation associated with contact lens use.

 

The recommended dose is one to two drops instilled into the affected eye(s) as needed or as directed by a physician. Patients should be instructed to wash their hands before using the eye drops and to avoid touching the tip of the dropper to any surface, including the eye.

 

The most common adverse reactions of Carboxymethylcellulose Sodium + Hypromellose ophthalmic drop include blurred vision & stickiness of the eyelash.

 

  • Patients should not use this medication if they have a known allergy to any of its components.
  • This medication is for topical ophthalmic use only and should not be ingested or used in the ears or nose.
  • Contact lenses should be removed before using the eye drops and may be reinserted 15 minutes after administration.
  • Patients should not drive or operate machinery until their vision clears after using the eye drops.
  • Patients with eye infections or injuries should not use this medication unless directed by a physician.
  • Prolonged use of this medication may lead to dependence on artificial tears.

 

Contraindication

Carboxymethylcellulose Sodium + Hypromellose ophthalmic drop is contraindicated in patients with a known hypersensitivity to any of its components.